HomeAboutMediaCareersSite MapContactSearch
Geron
PatientsProductsTechnology & ScienceInvestors
print
  • Product Pipeline
  • News Releases
  • Annual Reports
  • Events
  • Corporate Governance
  • Information Request

Corporate Governance

Geron has a commitment to good governance and business practices. In furtherance of this commitment we regularly monitor developments in the area of corporate governance and review our processes and procedures in light of such developments. Geron complies with the rules and regulations promulgated by the Securities and Exchange Commission (SEC) and the National Association of Securities Dealers (NASD), and we implement other corporate governance practices as we believe are in the best interest of the company and our stockholders.

Code of Conduct

In 2003, Geron adopted a Code of Conduct (the "Code of Conduct"), which is available below and also to any stockholder otherwise requesting a copy. All Geron employees, officers, and directors, including the Chief Executive Officer and Chief Financial Officer, are required to adhere to the Code of Conduct in discharging their work-related responsibilities. Employees are required to report any conduct that they believe in good faith to be an actual or apparent violation of the Code of Conduct. Amendments to the Code of Conduct, and any waivers from the Code of Conduct granted to directors or executive officers, will also be made available through this website as they are adopted.

In keeping with the Sarbanes-Oxley Act of 2002, the Audit Committee of the Board of Directors has established procedures for the receipt and handling of complaints received by the company regarding accounting, internal accounting controls or auditing matters. A copy of this policy is available below.

Committees of the Board of Directors

The Board maintains three standing committees - Compensation Committee, Audit Committee and Nominating Committee. Committee membership is determined by the Board, and all committee members are independent directors as determined by the Board. Each committee maintains a written charter detailing its authority and responsibilities. These charters are reviewed periodically as legislative and regulatory developments and business circumstances warrant and are available in their entirety below, as well as to any stockholder requesting a copy.

Stockholders wishing to communicate with the Board of Directors, or with a specific Board member, may do so by writing to the Board, or to the particular Board member, c/o David L. Greenwood, Corporate Secretary, Geron Corporation, 230 Constitution Drive, Menlo Park, CA 94025. All mail addressed in this manner will be delivered to the Chair or Chairs of the Committees with responsibilities touching most closely on the matters addressed in the communication.

Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the Exchange Act requires the company's directors and executive officers, and persons who own more than 10% of a registered class of the company's equity securities (collectively "Reporting Persons"), to file with the SEC initial reports of ownership and reports of changes in ownership of Common Stock and other equity securities of the company. Reporting Persons are required by SEC regulations to furnish the company with copies of all Section 16(a) forms they file.

To access Section 16(a) reports filed with the SEC, click on the link below to the SEC's website.

Adobe Acrobat Reader is required to view these files. Download it here.


  • View SEC Filings
  • View Code of Conduct
  • View Accounting Complaint Policy
  • View Audit Committee Charter
  • View Compensation Committee Charter
  • View Nominating Committee Charter

Visionary Therapeutics
Home | About | Media | Careers | Site Map | Contact | Search
Patients | Products | Technology & Science | Investors
Legal Disclaimer
Copyright © Geron 2010. All rights reserved.